Skip to main content

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Related professionals

Itziar Busquets Saez

Itziar Busquets Saez

Research technician
Molecular Imaging and Therapy
Read more
Victoria López Craver

Victoria López Craver

Psychiatry, Mental Health and Addictions
Read more
Claire Diot

Claire Diot

Administration and Management
Childhood Cancer and Blood Disorders
Read more
Mercedes López González

Mercedes López González

Main researcher
Kidney Physiopathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.